These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6794087)

  • 1. Cholinergic drug effects on visual discriminations: a signal detection analysis.
    Milar KS
    Psychopharmacology (Berl); 1981; 74(4):383-8. PubMed ID: 6794087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholinergic and non-cholinergic drugs on visual discrimination and delayed visual discrimination performance in rats.
    Andrews JS; Grützner M; Stephens DN
    Psychopharmacology (Berl); 1992; 106(4):523-30. PubMed ID: 1579625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the physostigmine stimulus in rats.
    Jung M; Perio A; Worms P; Soubrie P
    Psychopharmacology (Berl); 1988; 95(4):553-5. PubMed ID: 3145526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of cholinergic drugs on discriminative cues and self-stimulation produced by electrical stimulation of the ventral tegmental area.
    Druhan JP; Fibiger HC; Phillips AG
    Psychopharmacology (Berl); 1989; 97(3):331-8. PubMed ID: 2497481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists.
    Stone WS; Walser B; Gold SD; Gold PE
    Behav Neurosci; 1991 Apr; 105(2):264-71. PubMed ID: 2043273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of scopolamine and methscopolamine on brightness discrimination reinforced by opportunity for exploration.
    Leaton RN
    J Comp Physiol Psychol; 1969 May; 68(1):155-8. PubMed ID: 5793863
    [No Abstract]   [Full Text] [Related]  

  • 7. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of physostigmine and scopolamine on operant brightness discrimination in the rat.
    Leaton RN; Kreindler M
    Physiol Behav; 1972 Jul; 9(1):121-3. PubMed ID: 5080149
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
    Shannon HE; Bemis KG; Hendrix JC; Ward JS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine.
    Bartus RT; Johnson HR
    Pharmacol Biochem Behav; 1976 Jul; 5(1):39-46. PubMed ID: 825880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzepine.
    Shurtleff D; Raslear TG; Genovese RF; Simmons L
    Physiol Behav; 1992 Feb; 51(2):381-90. PubMed ID: 1557449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholinergic drugs on aversive operant behavior induced by dorsal central gray stimulation in rats.
    Moriyama M; Ichimaru Y; Gomita Y; Fukuda T
    Jpn J Pharmacol; 1985 Nov; 39(3):339-47. PubMed ID: 4094182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reappraisal of scopolamine effects on inhibition.
    Milar SK; Halgren CR; Heise GA
    Pharmacol Biochem Behav; 1978 Sep; 9(3):307-13. PubMed ID: 714980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scopolamine disrupts visual reversal without affecting the first discrimination.
    Soffie M; Lamberty Y
    Physiol Behav; 1987; 40(2):263-5. PubMed ID: 3628536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low dose scopolamine affects discriminability but not rate of forgetting in delayed conditional discrimination.
    Kirk RC; White KG; McNaughton N
    Psychopharmacology (Berl); 1988; 96(4):541-6. PubMed ID: 3149778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic and cholinergic action on neuronal activity during self-stimulation behavior in the rat.
    Olds ME; Ito M
    Neuropharmacology; 1973 Jun; 12(6):525-39. PubMed ID: 4725523
    [No Abstract]   [Full Text] [Related]  

  • 17. Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine.
    Bensadoun JC; Brooks SP; Dunnett SB
    Psychopharmacology (Berl); 2004 Jul; 174(3):396-405. PubMed ID: 14985934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat.
    Ray CA; Blin J; Chase TN; Piercey MF
    Neuropharmacology; 1992 Nov; 31(11):1193-9. PubMed ID: 1475026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain.
    Alberch J; Carman-Krzan M; Fabrazzo M; Wise BC
    Brain Res; 1991 Mar; 542(2):233-40. PubMed ID: 1851454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pesticides and drugs on working memory in rats: continuous delayed response.
    Heise GA; Hudson JD
    Pharmacol Biochem Behav; 1985 Oct; 23(4):591-8. PubMed ID: 3934688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.